AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Health reform law implementation issues including application of medical device tax to laboratory tests and laboraty fee schedule cuts; the oversight of laboratory-developed tests, HR 3207, the Modernizing Laboratory Test Standards for Patients Act; Budget Control Act of 2011(PL 112-225); in-office ancillary services exception to Stark law; HR 5651, Food and Drug Administration Reform Act, S. 3187, Food and Drug Administration Safety and Innovation Act, HR 6118, the Taking Essential Steps for Testing Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON DUBOIS | Vice President, Government Affairs |
| JO ANNE GLISSON | Senior Vice President |
| JENNIFER BULLARD MADSEN | Vice President, Policy and Medical Affairs |
| SCOTT VAN BUREN MCGOOHAN | Director, Regulatory and Reimbursement Affairs |
| ALAN MERTZ | President |
| FRANCESCA FIERRO O'REILLY | Vice President, Government Affairs |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.